Washington, Feb, 23 : The Food and Drug Administration (FDA) has given its approval to a highly cohesive anatomically shaped silicone-gel filled breast implant.
Natrelle 410 - manufactured by Allergan, Inc - has now been approved for the purpose of breast augmentation in adults - 22 and older - and in women of all ages - undergoing a breast reconstruction following cancer, CBS News reported.
Dr. Oren Lerman, a plastic surgeon at Lenox Hill Hospital's Institute for Comprehensive Breast Care in New York City, said that this is the latest in new generation of silicone implants which may provide a more natural "tear-drop" look compared to other options.
These silicone implants have more cross-linking in their gel than earlier ones that makes it more cohesive, which in turn makes the implants firmer.
Lerman said doctors sometimes refer to these implants as "Gummy Bear" implants because of their feel and consistency when held outside the body.
The FDA's approval is based on seven years of data collected from 941 women. (ANI)
- Marathon Pharma to sell decades-old drug to treat DMD for $89,000
- FedEx Launches FedEx Fulfillment for Small Business to Compete with Amazon
- CDC updates 2017 advisory for recommended flu shots
- Coca-Cola Helped by Strong North American Demand but Company Issues Lackluster Future Guidance
- Women with dense breasts more likely to develop breast cancer: study